|
KIAA1841 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.756200E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.910600E-01 |
| Normal-vs-Stage2 |
1.188830E-01 |
| Normal-vs-Stage3 |
1.708430E-01 |
| Normal-vs-Stage4 |
8.764000E-01 |
| Stage1-vs-Stage2 |
4.040800E-03 |
| Stage1-vs-Stage3 |
6.283400E-01 |
| Stage1-vs-Stage4 |
3.998800E-01 |
| Stage2-vs-Stage3 |
6.300900E-03 |
| Stage2-vs-Stage4 |
1.045430E-01 |
| Stage3-vs-Stage4 |
2.899200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.269000E-01 |
| Normal-vs-AfricanAmerican |
3.278200E-02 |
| Normal-vs-Asian |
1.477240E-01 |
| Caucasian-vs-AfricanAmerican |
3.313800E-02 |
| Caucasian-vs-Asian |
3.722600E-01 |
| AfricanAmerican-vs-Asian |
1.775370E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.698800E-01 |
| Normal-vs-Female |
4.297000E-01 |
| Male-vs-Female |
8.115000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.197970E-01 |
| Normal-vs-Age(41-60Yrs) |
9.920400E-01 |
| Normal-vs-Age(61-80Yrs) |
7.261200E-01 |
| Normal-vs-Age(81-100Yrs) |
8.309400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.044000E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.687410E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.755200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.809000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.465600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.419600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
5.937900E-02 |
| Classical-VS-Follicular |
8.123900E-03 |
| Classical-VS-Other |
7.954400E-01 |
| Classical-VS-Normal |
2.179000E-01 |
| Tall-VS-Follicular |
2.816900E-03 |
| Tall-VS-Other |
2.256000E-01 |
| Tall-VS-Normal |
8.738400E-03 |
| Follicular-VS-Other |
5.669800E-01 |
| Follicular-VS-Normal |
3.823600E-01 |
| Other-VS-Normal |
7.827600E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.663400E-01 |
| Normal-vs-N1 |
7.188000E-02 |
| N0-vs-N1 |
2.726200E-02 |
|
|
